Annovis BioAdvance News Portfolio News

Annovis Bio Announces Pricing of Initial Public Offering

By WebmasterJanuary 28, 2020November 1st, 2024No Comments

Annovis Bio Announces Pricing of Initial Public Offering

Previous PostAnnovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Next PostBainbridge Health Will Provide Children's Mercy Kansas City with Its Med O.S.© Infusion Pump Platform to Ensure the Safe Use of IV Medications